Security key
3622AW304
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 137,814
- Total 13F value
- $49,709
- Share change
- +65,736
- SEC-reported price per share
- $0.36
- Number of holders
- 7
- Value change
- -$54,583
- Number of buys
- 6
- Number of sells
- 1
Report period
Q3 2024
Institutions
7
Top holders
7
GRI full security history
Ownership snapshot
Full 13F holder table
GRI Bio, Inc. SEC filings
GRI Bio, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of GRI - GRI Bio, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Albert Agro
Disclosed value leader
Albert Agro
Comparable rows
0/12
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $702,531
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Albert Agro has the largest disclosed position value at $702.5K.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Albert Agro's linked filing trail.
Disclosed position value
Top 5
Albert Agro
$702.5K
ARMISTICE CAPITAL, LLC
$96.4K
Marella Thorell
$38.8K
UBS Group AG
$34.5K
Ofir Levi
$20.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Albert Agro |
3/4/5
Chief Medical Officer
|
—
denominator unverified
|
$702,531
172,189 shares
|
— | 21 Apr 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$96,397
50,207 shares
|
— | 30 Jun 2024 |
| Marella Thorell |
3/4/5
Director
|
—
denominator unverified
|
$38,784
9,506 shares
|
— | 13 Dec 2022 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$34,493
17,965 shares
|
— | 30 Jun 2024 |
| Ofir Levi |
3/4/5
Director
|
—
denominator unverified
|
$20,571
30,000 shares
|
— | 14 May 2021 |
| Penny Toren |
3/4/5
SVP, Regul Affairs & Prog Mgmt
|
—
denominator unverified
|
$17,143
25,000 shares
|
— | 14 May 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
137,814
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
5
Q3 2024 holders
7
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|